LONDON, 03rd June 2019 –WINCHESTER MD LIMITED (“Winchester” or the “Company”) is pleased to announce that on 28thMay 2019 the Company appointed Ewan Phillips as the Chief Financial Officer of the Company.
Ewan started his career at Deloitte focusing initially on audit and subsequently corporate finance. After Deloitte he spent 17 years on the Board of Deltex Medical Group plc (LON:DEMG) – an innovative UK Life Sciences company, where, as CFO, he led the company to an IPO on AIM gaining valuable exposure to raising capital, investor relations, corporate governance and scaling the business from 15 to over 100 employees and 20x sales growth. Ewan has completed over 50 financing transactions raising over £250 million and over 50 M&A transactions with an aggregate value in excess of £1 billion. He is a Chartered Accountant.
Faz Moshfeghi, CEO and Co-founder of the Company added: “As the business of the Company continues to grow and gather momentum the management made the recent decision to find and bring on board a relevant and successful accounting professional as our CFO. In Ewan we have secured a very experienced and important member of the team to assist with our aggressive acquisition and markets strategy. He will be a valuable member of the team that adds to and complements the talents of the existing management structure that will further enable us.”
For more information, please visitwww.winchestermd.com
On Behalf of the Board,
About Winchester MD Limited
Winchester MD is a vertically integrated European cannabis company based out of London, UK. The Company was founded in 2018 with an initial focus on CBD Wellness through a revenue producing online retail superstore platform HempElf www.hempelf.com. The Company offers a variety of CBD branded products through its on line superstore and continues to develop and market new products in the CBD Wellness category. In 2019 the Company has expanded into other verticals in the cannabis sector with the vision of becoming a global cannabis leader with cultivation, extraction, CBD wellness and research and development.